scholarly journals Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease

Biochemistry ◽  
2015 ◽  
Vol 54 (35) ◽  
pp. 5414-5424 ◽  
Author(s):  
John M. Louis ◽  
Lalit Deshmukh ◽  
Jane M. Sayer ◽  
Annie Aniana ◽  
G. Marius Clore
Keyword(s):  
Α Helix ◽  
2006 ◽  
Vol 81 (1) ◽  
pp. 362-373 ◽  
Author(s):  
Jan Balzarini ◽  
Kristel Van Laethem ◽  
Dirk Daelemans ◽  
Sigrid Hatse ◽  
Antonella Bugatti ◽  
...  

ABSTRACT Pradimicin A (PRM-A), an antifungal nonpeptidic benzonaphtacenequinone antibiotic, is a low-molecular-weight (molecular weight, 838) carbohydrate binding agent (CBA) endowed with a selective inhibitory activity against human immunodeficiency virus (HIV). It invariably inhibits representative virus strains of a variety of HIV-1 clades with X4 and R5 tropisms at nontoxic concentrations. Time-of-addition studies revealed that PRM-A acts as a true virus entry inhibitor. PRM-A specifically interacts with HIV-1 gp120 and efficiently prevents virus transmission in cocultures of HUT-78/HIV-1 and Sup T1 cells. Upon prolonged exposure of HIV-1-infected CEM cell cultures, PRM-A drug pressure selects for mutant HIV-1 strains containing N-glycosylation site deletions in gp120 but not gp41. A relatively long exposure time to PRM-A is required before drug-resistant virus strains emerge. PRM-A has a high genetic barrier, since more than five N-glycosylation site deletions in gp120 are required to afford moderate drug resistance. Such mutated virus strains keep full sensitivity to the other known clinically used anti-HIV drugs. PRM-A represents the first prototype compound of a nonpeptidic CBA lead and, together with peptide-based lectins, belongs to a conceptually novel type of potential therapeutics for which drug pressure results in the selection of glycan deletions in the HIV gp120 envelope.


2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Xing-Jie Zhang ◽  
Rui-Rui Wang ◽  
Huan Chen ◽  
Rong-Hua Luo ◽  
Liu-Meng Yang ◽  
...  

2019 ◽  
Author(s):  
Kengo Hirao ◽  
Sophie Andrews ◽  
Kimiko Kuroki ◽  
Hiroki Kusaka ◽  
Takashi Tadokoro ◽  
...  

SummaryThe HIV accessory protein Nef plays a major role in establishing and maintaining infection, particularly through immune evasion. Many HIV-2 infected people experience long-term viral control and survival, resembling HIV-1 elite control. HIV-2 Nef has overlapping but also distinct functions from HIV-1 Nef. Here we report the crystal structure of HIV-2 Nef core. The dileucine sorting motif forms a helix bound to neighboring molecules, and moreover, isothermal titration calorimetry demonstrated that the CD3 endocytosis motif can directly bind to HIV-2 Nef, ensuring AP-2 mediated endocytosis for CD3. The highly-conserved C-terminal region forms a α-helix, absent from HIV-1. We further determined the structure of SIV Nef harboring this region, demonstrating similar C-terminal α-helix, which may contribute to AP-1 binding for MHC-I downregulation. These results provide new insights into the distinct pathogenesis of HIV-2 infection.


Biochemistry ◽  
1995 ◽  
Vol 34 (29) ◽  
pp. 9282-9287 ◽  
Author(s):  
Sergei V. Gulnik ◽  
Leonid I. Suvorov ◽  
Beishan Liu ◽  
Betty Yu ◽  
Barry Anderson ◽  
...  

2019 ◽  
Vol 25 (30) ◽  
pp. 7265-7269 ◽  
Author(s):  
Debabrata Maity ◽  
Sunil Kumar ◽  
Francesca Curreli ◽  
Asim K. Debnath ◽  
Andrew D. Hamilton
Keyword(s):  
Tar Rna ◽  
Α Helix ◽  

PLoS Biology ◽  
2020 ◽  
Vol 18 (12) ◽  
pp. e3001010
Author(s):  
Eva Bons ◽  
Christine Leemann ◽  
Karin J. Metzner ◽  
Roland R. Regoes

An often-returning question for not only HIV-1, but also other organisms, is how predictable evolutionary paths are. The environment, mutational history, and random processes can all impact the exact evolutionary paths, but to which extent these factors contribute to the evolutionary dynamics of a particular system is an open question. Especially in a virus like HIV-1, with a large mutation rate and large population sizes, evolution is expected to be highly predictable if the impact of environment and history is low, and evolution is not neutral. We investigated the effect of environment and mutational history by analyzing sequences from a long-term evolution experiment, in which HIV-1 was passaged on 2 different cell types in 8 independent evolutionary lines and 8 derived lines, 4 of which involved a switch of the environment. The experiments lasted for 240–300 passages, corresponding to approximately 400–600 generations or almost 3 years. The sequences show signs of extensive parallel evolution—the majority of mutations that are shared between independent lines appear in both cell types, but we also find that both environment and mutational history significantly impact the evolutionary paths. We conclude that HIV-1 evolution is robust to small changes in the environment, similar to a transmission event in the absence of an immune response or drug pressure. We also find that the fitness landscape of HIV-1 is largely smooth, although we find some evidence for both positive and negative epistatic interactions between mutations.


2002 ◽  
Vol 38 ◽  
pp. 113-127 ◽  
Author(s):  
Ben M Dunn

The peptidase of the HIV type 1 (HIV PR) is required for the replication of and further infection by the virus. A concerted effort has taken place in the past 15 years to understand the properties of this enzyme, as it serves as an excellent drug target for control of the virus. Owing to drug pressure, many mutations arise during turnover of the virus and some of these lead to resistance to the effects of the inhibitors. Recent advances in the understanding of the changes these mutations cause to the enzyme and its interaction with substrates and inhibitors have been described. In addition, studies of closely related retroviral enzymes from simian immunodeficiency virus, feline immunodeficiency virus and HIV-2 have expanded the structure-function paradigm. The role of the flexibility of ligands and of the enzyme in active-site interactions is discussed.


2003 ◽  
Vol 278 (20) ◽  
pp. 18110-18116 ◽  
Author(s):  
Emmanuel Coeytaux ◽  
Dominique Coulaud ◽  
Eric Le Cam ◽  
Olivier Danos ◽  
Antoine Kichler

2006 ◽  
Vol 36 (4) ◽  
pp. 264-271 ◽  
Author(s):  
Africa Holguín ◽  
Carlos Suñe ◽  
François Hamy ◽  
Vincent Soriano ◽  
Thomas Klimkait

2020 ◽  
Author(s):  
Shahid N. Khan ◽  
John D. Persons ◽  
Michel Guerrero ◽  
Tatiana V. Ilina ◽  
Masayuki Oda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document